SUISPIRIN, 1000 MG/G, ORAL POWDER FOR PIGS

Country: Ireland

Language: English

Source: HPRA (Health Products Regulatory Authority)

Buy It Now

Active ingredient:

ACETYLSALICYLIC ACID

Available from:

aniMedica GmbH

ATC code:

QN02BA01

INN (International Name):

ACETYLSALICYLIC ACID

Dosage:

1000 mg/g

Pharmaceutical form:

Oral Powder

Prescription type:

POM

Therapeutic group:

Porcine

Therapeutic area:

Acetylsalicylic acid

Therapeutic indications:

Miscellaneous

Authorization status:

Authorised

Authorization date:

2011-10-28

Summary of Product characteristics

                                SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Suispirin, 1000 mg/g, oral powder for pigs
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
1.0 g powder contains:
ACTIVE SUBSTANCE:
Acetylsalicylic acid
1000
mg 
3 PHARMACEUTICAL FORM
Oral powder.
White to almost white powder.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Pigs.
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Pig:
Supportive treatment for reduction of pyrexia in combination with, appropriate anti-infective therapy, if necessary.
4.3 CONTRAINDICATIONS
Do not use in case of hypersensitivity to the active substance or in cases of gastrointestinal
irritation and ulcers, chronic gastro-intestinal disorders, bronchospasm, liver function impairment or nephropathies.
Do not use in pregnant or lactating sows.
Do not use in piglets less than 4 weeks of age.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
In combined treatment with tetracyclines, a treatment interval of at least one hour between the two active agents is
recommended.
HEALTH PRODUCTS REGULATORY AUTHORITY
________________________________________________________________________________________________________________________
_Date Printed 16/05/2016_
_CRN 7023232_
_page number: 1_
4.5 SPECIAL PRECAUTIONS FOR USE
SPECIAL PRECAUTIONS FOR USE IN ANIMALS
It must be ensured that the animals consume sufficient water during treatment.
Given that Suispirin may inhibit clotting of blood, it is recommended that elective surgery should not be performed on
animals within 7 days after the end of treatment.
SPECIAL PRECAUTIONS TO BE TAKEN BY THE PERSON ADMINISTERING THE VETERINARY MEDICINAL PRODUCT TO ANIMALS
Do not eat, drink or smoke whilst using this product. Contact via the skin or mucous membranes of the user must be
avoided due to the risk of sensitisation. If you know t
                                
                                Read the complete document
                                
                            

Search alerts related to this product